Wire Stories

EpiAxis Therapeutics & Peptilogics Enter Strategic Drug Discovery Partnership

SYDNEY & PITTSBURGH--(BUSINESS WIRE)--EpiAxis Therapeutics, a leading epigenetics company with a focus on the treatment,…

BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care

Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines…

L&T Technology Services appoints Nandini P. Nair as Global General Counsel

BENGALURU, India--(BUSINESS WIRE)--$LTTS #DiversityInclusion--L&T Technology Services Limited, a global leading pure-play engineering services company, today…

Asia Crop Farming Company Database 2022: The Largest 5000 Companies Ranked by Revenue – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Database of Crop Farming Companies in Asia" database has been added to ResearchAndMarkets.com's…

China Console Games Market Analysis Report 2022: Nearly 80% of Game Revenue is Generated by Grey Market Sales – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China Console Games 2022" report has been added to ResearchAndMarkets.com's offering. Console gamers…

Preschool Market in India 2022-2026: Increasing Participation of Women in the Labor Force & Increased Emphasis on Teacher Training Driving Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Preschool Market in India 2022-2026" report has been added to ResearchAndMarkets.com's offering. The…

Yellow River Helps Boost Cultural Tourism in Dongying

DONGYING, China--(BUSINESS WIRE)--Dongying, a coastal city in East China's Shandong province, is working to promote…

Avolon Agrees Transaction for 20 A330neo Aircraft With Malaysia Aviation Group

Airbus A330-900neo aircraft to be powered by Rolls-Royce Transaction announced by Malaysia’s Minister for Transport…

eCloudvalley Partners up with The Royal Group to Accelerate Digital Transformation in Cambodia

SINGAPORE--(BUSINESS WIRE)--eCloudvalley Digital Technology, a leading provider of digital transformation in Asia, has announced the…

ENHERTU® Significantly Delayed Disease Progression in DESTINY-Breast02 Phase 3 Trial Versus Physician’s Choice of Treatment in Patients with HER2 Positive Metastatic Breast Cancer

Results consistent with previous trials, reinforcing benefit of Daiichi Sankyo and AstraZeneca’s ENHERTU in previously…